- Home
- EXAS vs LECO Comparison
EXAS vs LECO Comparison
Compare EXAS & LECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- LECO
- Stock Information
- Founded
- EXAS 1995
- LECO 1895
- Country
- EXAS United States
- LECO United States
- Employees
- EXAS N/A
- LECO N/A
- Industry
- EXAS Medical Specialities
- LECO Industrial Machinery/Components
- Sector
- EXAS Health Care
- LECO Industrials
- Exchange
- EXAS Nasdaq
- LECO Nasdaq
- Market Cap
- EXAS 11.0B
- LECO 13.1B
- IPO Year
- EXAS N/A
- LECO N/A
- Fundamental
- Price
- EXAS $64.82
- LECO $241.16
- Analyst Decision
- EXAS Strong Buy
- LECO Buy
- Analyst Count
- EXAS 21
- LECO 9
- Target Price
- EXAS $69.24
- LECO $242.33
- AVG Volume (30 Days)
- EXAS 2.0M
- LECO 286.6K
- Earning Date
- EXAS 11-03-2025
- LECO 10-30-2025
- Dividend Yield
- EXAS N/A
- LECO 1.24%
- EPS Growth
- EXAS N/A
- LECO 0.60
- EPS
- EXAS N/A
- LECO 8.90
- Revenue
- EXAS $2,939,949,000.00
- LECO $4,098,850,999.00
- Revenue This Year
- EXAS $16.68
- LECO $7.07
- Revenue Next Year
- EXAS $12.12
- LECO $5.73
- P/E Ratio
- EXAS N/A
- LECO $27.17
- Revenue Growth
- EXAS 12.55
- LECO 0.10
- 52 Week Low
- EXAS $38.81
- LECO $161.11
- 52 Week High
- EXAS $72.83
- LECO $249.19
- Technical
- Relative Strength Index (RSI)
- EXAS 81.05
- LECO 54.38
- Support Level
- EXAS $63.05
- LECO $238.31
- Resistance Level
- EXAS $62.31
- LECO $245.08
- Average True Range (ATR)
- EXAS 1.57
- LECO 5.66
- MACD
- EXAS 0.27
- LECO 0.71
- Stochastic Oscillator
- EXAS 92.60
- LECO 77.25
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About LECO Lincoln Electric Holdings Inc.
Lincoln Electric is a leading manufacturer of welding, cutting, and brazing products. Its portfolio includes arc-welding solutions, plasma and oxy-fuel cutting systems, and brazing and soldering alloys, as well as automation solutions. Lincoln Electric serves clients in the general fabrication, heavy industries, automotive, construction, shipbuilding, energy, and process industries, among other end markets. Based in Cleveland, Lincoln Electric has operations in 19 countries and has 11,000 employees worldwide. The company generated roughly $4 billion in sales in 2024.